Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Ki67/MKI67 Polyclonal Antibody

Catalog #:   PHE46101 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P46013
Overview

Catalog No.

PHE46101

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human Ki67/MKI67 (Gly3088-Lys3235).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:2000-1:8000

Target

MKI67,Proliferation marker protein Ki-67,Antigen Ki67,Antigen KI-67,Antigen identified by monoclonal antibody Ki-67

Purification

Purified by antigen affinity column.

Accession

P46013

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with Ki67/MKI67 antibody (PHE46101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 19 kDa
    Observed MW: 19 kDa
References

Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma., PMID:40512454

Histopathologic Progression of Autoimmune Atrophic Gastritis: A Retrospective Review of 180 Specimens From 32 Patients., PMID:40509896

Spatial discovery of pyrotinib overcoming HER2-positive breast cancer resistance by breaking fibroblast-induced immune barriers., PMID:40480079

B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer., PMID:40463377

Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma?, PMID:40448797

Clinicopathological comparison of eccrine poroma and porocarcinoma: Ki-67 index is not a decisive factor., PMID:40445996

[Clinical and morphological features of adenomatoid odontogenic tumor of the mandible in early childhood]., PMID:40445054

Engineered E. coli OMVs Carrying the Membrane-Binding hGC33 Fragment Precisely Target Liver Cancer and Effectively Treat Tumor., PMID:40433120

Mesenchymal stem cells reduce the genotoxic effect of lead acetate in the testis of male rats and induce testicular cellular proliferation indicated by 16S rRNA sequence, increase the proliferation marker Ki-67 and a reduction in the apoptosis marker caspase-3., PMID:40426269

Investigating Anti-Tumor Effects of Irisin in Cervical Cancer Cells: Cell Viability, Migration, and Tumor-Associated Macrophage Polarization., PMID:40415369

CCNA2 and CCND2 are differentially involved in β-cell proliferation in perinatal Japanese autopsied subjects., PMID:40411825

Mass Cytometry Analysis of High-Dimensional Single-Cell Immune Profiles in ZF2001-Vaccinated Patients Infected with SARS-CoV-2., PMID:40384795

Gestational trophoblastic diseases - literature review and atypical case reports., PMID:40384188

Porustobart (HBM4003) plus toripalimab as second-line therapy in patients with advanced hepatocellular carcinoma: a multicenter, open-label, phase I study., PMID:40378055

Asiaticoside enhances the anti-tumor effect of anti-PDL1 by regulating T cell activity through increasing LCK activity., PMID:40373489

Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study., PMID:40352587

Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study., PMID:40351326

[Mechanism of Naoxintong Capsules in treatment of rats with multiple cerebral infarctions and myocardial injury based on HIF-1α/VEGF pathway]., PMID:40350881

Comparison of the bone remodeling in the midpalatal suture during maxillary expansion between young and middle-aged mice., PMID:40324615

Potential of Ultrashort Pulsed Electric Fields to Disrupt Dense Structure in Glioma Tumors., PMID:40305246

Investigating tumor immunogenicity as a determinant of differential abscopal effects., PMID:40302523

Roles of GDF9 and BMP15 in equine follicular development: in vivo content and in vitro effects of IGF1 and cortisol on granulosa cells., PMID:40289073

Prognostic and recurrence risk predictive values of tumor infiltrating lymphocytes in HER2-low breast cancer., PMID:40287914

Treatment outcomes of BTK inhibitors and venetoclax with or without anti-CD20 monoclonal antibody in relapsed or refractory mantle cell lymphoma., PMID:40278919

PD - L1 (SP263) expression correlates with pathological aggressive parameters in prostate cancer., PMID:40273724

The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis., PMID:40270954

Prognostic Significance of Ki67 Expression in Prostate Cancer in Nigerians: A Single-Center Study., PMID:40260342

Myoepithelial carcinoma of submaxillary gland: A case report., PMID:40230425

The Protective Effects of MSC-Derived Exosomes Against Chemotherapy-Induced Parotid Gland Cytotoxicity., PMID:40223864

Correlation of immune profiling and exceptional response to immune checkpoint inhibitor in a patient with head and neck cancer., PMID:40214377

Immunohistochemical expression of PDL1 and Ki67 in glioma and its correlation with treatment and overall survival., PMID:40214367

Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response., PMID:40179327

IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas., PMID:40176156

Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2., PMID:40145086

Diffuse large B-cell lymphoma with partial low Ki67 proliferation index., PMID:40138154

Distinguishing Low Expression Levels of Human Epidermal Growth Factor Receptor 2 in Breast Cancer: Insights from Qualitative and Quantitative Magnetic Resonance Imaging Analysis., PMID:40137571

Immunohistochemical insights into the pathogenesis of colonic sessile serrated lesions., PMID:40135194

Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review., PMID:40124876

Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit., PMID:40100476

BRAF p.V600E-Negative Langerhans Cell Histiocytosis Associated with a Periapical Cyst: A Case Presentation with Broad Review of the Differential Diagnosis and Disease Pathophysiology., PMID:40088330

Development and Characterization of the [177Lu]Lu-Labeled Anti-CDH17 Nanobody Derivative for Radioimmunotherapy in the Gastric Cancer Xenograft Model., PMID:40088168

The Morphological Dependence of PEDOT on the Supporting Electrolytes Used and the Acquisition of Gold Nanoparticles with a View to Their Use in the Covalent Modification of the Ki-67 Antibody., PMID:40076164

Gut IgA-antibody secreting cells segregate into four Blimp1+ subsets based on differential expression of IgA and Ki-67 and are retained following prolonged αCD20 B cell depletion in mice., PMID:40073093

IL-4 alters TLR7-induced B cell developmental program in lupus., PMID:40068727

Appraising histone H4 lysine 5 lactylation as a novel biomarker in breast cancer., PMID:40065036

Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinoma., PMID:40063612

Defective Incisor Development in Smad Interacting Protein 1 (Sip1) Null Mice., PMID:40062516

Assessment of the Efficacy and Pulmonary Toxicity of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer in a Tertiary Center in the United Arab Emirates., PMID:40062154

Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis., PMID:40060399

Immunohistochemical expression of epidermal growth factor receptor: prognostic value in HER2 positive breast cancer., PMID:40059383

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Ki67/MKI67 Polyclonal Antibody [PHE46101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only